trinitrobenzenesulfonic acid has been researched along with Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contractor, N; Fuss, I; Hoffmann, V; Iwaki, S; Kelsall, BL; la Sala, A; Lahey, E; Leon, F; Marth, T; Strober, W | 1 |
| Ando, T; Goto, H; Ishiguro, K; Maeda, O; Niwa, Y; Ohmiya, N | 1 |
2 other study(ies) available for trinitrobenzenesulfonic acid and Dermatitis
| Article | Year |
|---|---|
Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis.
Topics: Adoptive Transfer; Animals; Antibodies; CD4-Positive T-Lymphocytes; Cells, Cultured; Colitis; Dermatitis; Disease Models, Animal; Female; Inflammation Mediators; Injections, Intravenous; Macrophage-1 Antigen; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Psoriasis; Trinitrobenzenesulfonic Acid | 2006 |
Acetate inhibits NFAT activation in T cells via importin beta1 interference.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; beta Karyopherins; Colitis; Dermatitis; Dinitrofluorobenzene; Enzyme Activation; Fatty Acids, Volatile; Female; Humans; Interleukin-2; Jurkat Cells; Mice; Mice, Inbred BALB C; NF-kappa B; NFATC Transcription Factors; Protein Transport; T-Lymphocytes; Trinitrobenzenesulfonic Acid | 2007 |